Improving the quality of life of Parkinson's disease patients

THE NEED: 1 vs 8,765

"I see my neurologist every six months for a thirty-minute session and thus spend every year a total of one hour being observed with the UPDRS. That leaves 8,765 hours per year when my disease is not being monitored."

Swedish patient and advocate Sara Riggare, from the book ‘Brainstorms, the race to unlock the mysteries of Parkinson’s disease’, by John Palfreman, Scientific American, 2015

NeuroPath's value proposition:

Improved Health Outcomes at Lower Cost


NeuroPath provides a medical grade health data platform from which to develop actionable & adaptive clinical support to improve health outcomes

Our Services


3D Marker-less Motion


Using the latest marker-less 3D motion capturing technology to monitor patients in a clinical and home environment.



NeuroPath’s core algorithms are created and trained from user generated health data through a host of different devices, e.g. Sensors, connected devices, applications, health records and quality of life surveys.



Our patient-scentric interface allows patients & neurologists to monitor disease progression and involves all care path sentinels.





IP Partners:

Our Projects

Project KU Leuven, Research Group for Neuromotor Rehabilitation & Research Group for Musculoskeletal Rehabilitation, Faculty of Kinesiology and Rehabilitation Sciences:

The main objectives of this research protocol are:

  • Validation of automated 3D marker-less motion capturing for home-based evaluation of motor disorders and rehabilitative exercises in Parkinson’s disease patients
  • Mono-centric study: screening tests to evaluate motor and cognitive function in Parkinson's disease.
  • Motion registration of execution of motor evaluation of Parkinson's disease severity (motor disorders) and rehabilitation exercises recommended for Parkinson's patients.

Principal investigator: Prof. Sabine Verschueren

Project Heilig Hart Ziekenhuis Lier & Mobilab:

The main objectives of this research protocol are:

  • The development of a standardized protocol for an objective, unbiased, assessment of PD motor symptoms severity by different Board-certified neurologists
  • The technological assessment of the quality of each of the 3D marker-less motion capturing devices and the analyses of differences in producing the kinematic parameters
  • The assessment of variability of pre- and post-medication for a sample of Parkinson’s disease patients, independent of PD stage
  • The variability of motor score post-medication at different moments of the day
  • The possible effect of exercises on the motor score post-medication
  • Patient feedback on the patient-friendliness of the NeuroPath solution (e.g. intrusiveness)

Principal investigator: Dr. Peter Dedeken

Project CHU Liège:

The main objectives of this research protocol are:

  • the development of a standardized protocol for a) an objective, unbiased assessment of the severity of motor symptoms of Parkinson's disease at home; b) continuous monitoring of activity and sedentary levels of patients. This protocol uses inertial measurement units integrated in a 3D marker-less motion capturing device and wearables such as the use of connected watches
  • to monitor the motor and non-motor (sleep) characteristics of Parkinson's disease in the usual living environment of patients while the patient is moving freely or during specific physical exercises associated with a 20-week home rehabilitation program designed collaboratively by a physician and a physiotherapist, using a 3D marker-less motion capturing device and a connected watch

Principal investigator: Dr. Gaëtan Garraux

For more information about the solutions & services of NeuroPath, please contact us!

+32 472 74 1671

Chemin du Cyclotron 6

1348 Louvain-La-Neuve


© 2018 NeuroPath.